Comparing the protection of heterologous booster of inhaled Ad5-nCoV vaccine and hybrid immunity against Omicron BA.5 infection: a cohort study of hospital staff in China

被引：0
|
作者：
Kai Wang [1 ]
Ting Zeng [1 ]
Zihao Guo [2 ]
Jing Liang [3 ]
Shengzhi Sun [4 ]
Yongkang Ni [5 ]
Chunyan Yan [3 ]
Liang Yin [3 ]
Lan Wang [3 ]
Hui Li [6 ]
Kailu Wang [2 ]
Marc K.C. Chong [7 ]
Naijun Tang [7 ]
Jianghong Dai [8 ]
Zhaohui Luo [9 ]
Shi Zhao [10 ]
机构：
[1] Xinjiang Medical University,Department of Medical Engineering and Technology
[2] Chinese University of Hong Kong,JC School of Public Health and Primary Care
[3] The Sixth Affiliated Hospital of Xinjiang Medical University,Department of Epidemiology and Biostatistics, School of Public Health
[4] Capital Medical University,School of Public Health
[5] Xinjiang Medical University,School of Public Health
[6] Central Laboratory of Xinjiang Medical University,Tianjin Key Laboratory of Environment, Nutrition and Public Health
[7] CUHK Shenzhen Research Institute,Key Laboratory of Prevention and Control of Major Diseases in the Population (MoE)
[8] Tianjin Medical University,undefined
[9] Tianjin Medical University,undefined
[10] Tianjin Medical University,undefined
来源：
BMC Infectious Diseases | / 24卷 / 1期
关键词：
SARS-CoV-2; Inhaled Ad5-nCoV vaccine; Vaccine effectiveness; Serological IgG antibody;
D O I：
10.1186/s12879-024-10250-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 25 条
  • [21] Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
    Ciesla, Allison Avrich
    Wiegand, Ryan E.
    Smith, Zachary R.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Miller, Joseph
    Accorsi, Emma K.
    Verani, Jennifer R.
    Shang, Nong
    Derado, Gordana
    Pilishvili, Tamara
    Link-Gelles, Ruth
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
  • [22] An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5-Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China
    Wang, Fu-Zhen
    Zhang, Chun-Huan
    Tang, Lin
    Rodewald, Lance E.
    Wang, Wen
    Liu, Si-Yu
    Wang, Wen-Ji
    Wu, Dan
    Liu, Qian-Qian
    Wang, Xiao-Qi
    Huang, Li-Fang
    Huang, Ao-Di
    Bao, Li-Ming
    Zhang, Zhou-Bin
    Yin, Zun-Dong
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (01): : 117 - 121
  • [23] Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
    Fabiani, Massimo
    Mateo-Urdiales, Alberto
    Sacco, Chiara
    Fotakis, Emmanouil Alexandros
    Rota, Maria Cristina
    Petrone, Daniele
    Bressi, Marco
    Del Manso, Martina
    Siddu, Andrea
    Fedele, Giorgio
    Stefanelli, Paola
    Bella, Antonino
    Riccardo, Flavia
    Palamara, Anna Teresa
    Rezza, Giovanni
    Brusaferro, Silvio
    Pezzotti, Patrizio
    EUROSURVEILLANCE, 2023, 28 (08) : 8 - 14
  • [24] Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
    Jia, Siyue
    Yin, Zundong
    Pan, Hongxing
    Wang, Fuzhen
    Liu, Xiaoqiang
    Wang, Qing
    Zhang, Li
    Tang, Jihai
    Yang, Hao
    Du, Jiangbo
    Wang, Zhiguo
    Jin, Pengfei
    Peng, Zhihang
    Tang, Rong
    Kang, Guodong
    Wang, Xuewen
    Li, Simin
    Wang, Weixiao
    Li, Jingxin
    Shen, Hongbing
    Zhu, Fengcai
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [25] Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France
    Auvigne, Vincent
    Tchuem, Cynthia Raissa Tamandjou
    Schaeffer, Justine
    Vaux, Sophie
    Du Chatelet, Isabelle Parent
    VACCINE, 2023, 41 (38) : 5490 - 5493
123